Literature DB >> 9006319

Expression of the receptor for complement C5a (CD88) is up-regulated on reactive astrocytes, microglia, and endothelial cells in the inflamed human central nervous system.

P Gasque1, S K Singhrao, J W Neal, O Götze, B P Morgan.   

Abstract

C5a receptor (C5aR, CD88) is a receptor originally described on neutrophils and monocyte-macrophages but recently found on hepatocytes, epithelial cells, endothelial cells, and tissue mast cells. We recently reported that human fetal astrocytes expressed a functional C5aR in vitro. Here we examine C5aR expression in adult brain cultures by immunostaining with six different anti-C5aRs and show that C5aR is expressed constitutively by astrocytes, microglia, and fibroblast-like cells but not by oligodendrocytes. In fetal brain cultures we confirmed that astrocytes constitutively expressed C5aR and demonstrated that fetal microglia and fibroblast-like cells but not oligodendrocytes and neurones expressed C5aR. Incubation with inflammatory cytokines (interferon gamma, interleukin-1, and tumor necrosis factor alpha) or phorbol ester failed to induce or up-regulate C5aR expression on fetal or adult brain cells. Immunohistochemistry was performed to determine the expression and distribution of C5aR in the normal and inflamed brain. In the normal brain C5aR was minimally expressed, whereas in inflamed brains from a variety of pathologies, C5aR expression was greatly up-regulated on reactive astrocytes and microglia and to a lesser extent on endothelial cells. We propose that expression of C5aR is a marker of central nervous system inflammation, and that C5aR expression on brain cells in inflammation plays an important role in cell activation and recruitment (gliosis).

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9006319      PMCID: PMC1858516     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  24 in total

Review 1.  Expression of complement in the brain: role in health and disease.

Authors:  B P Morgan; P Gasque
Journal:  Immunol Today       Date:  1996-10

2.  Characterization of a receptor for C5a anaphylatoxin on human eosinophils.

Authors:  N P Gerard; M K Hodges; J M Drazen; P F Weller; C Gerard
Journal:  J Biol Chem       Date:  1989-01-25       Impact factor: 5.157

3.  Role of complement in the aetiology of Pick's disease?

Authors:  S K Singhrao; J W Neal; P Gasque; B P Morgan; G R Newman
Journal:  J Neuropathol Exp Neurol       Date:  1996-05       Impact factor: 3.685

4.  Development of oligodendrocytes and Schwann cells studied with a monoclonal antibody against galactocerebroside.

Authors:  B Ranscht; P A Clapshaw; J Price; M Noble; W Seifert
Journal:  Proc Natl Acad Sci U S A       Date:  1982-04       Impact factor: 11.205

5.  C5a induction of human interleukin 1. Synergistic effect with endotoxin or interferon-gamma.

Authors:  S Okusawa; C A Dinarello; K B Yancey; S Endres; T J Lawley; M M Frank; J F Burke; J A Gelfand
Journal:  J Immunol       Date:  1987-10-15       Impact factor: 5.422

6.  Identification and characterization of the complement C5a anaphylatoxin receptor on human astrocytes.

Authors:  P Gasque; P Chan; M Fontaine; A Ischenko; M Lamacz; O Götze; B P Morgan
Journal:  J Immunol       Date:  1995-11-15       Impact factor: 5.422

7.  Expression of functional receptors for human C5a anaphylatoxin (CD88) on the human hepatocellular carcinoma cell line HepG2. Stimulation of acute-phase protein-specific mRNA and protein synthesis by human C5a anaphylatoxin.

Authors:  R R Buchner; T E Hugli; J A Ember; E L Morgan
Journal:  J Immunol       Date:  1995-07-01       Impact factor: 5.422

8.  Differential expression of complement receptors on human basophils and mast cells. Evidence for mast cell heterogeneity and CD88/C5aR expression on skin mast cells.

Authors:  W Füreder; H Agis; M Willheim; H C Bankl; U Maier; K Kishi; M R Müller; K Czerwenka; T Radaszkiewicz; J H Butterfield; G W Klappacher; W R Sperr; M Oppermann; K Lechner; P Valent
Journal:  J Immunol       Date:  1995-09-15       Impact factor: 5.422

Review 9.  Structure, function and cellular expression of complement anaphylatoxin receptors.

Authors:  R A Wetsel
Journal:  Curr Opin Immunol       Date:  1995-02       Impact factor: 7.486

10.  Expression of the receptors for the C5a anaphylatoxin, interleukin-8 and FMLP by human astrocytes and microglia.

Authors:  M Lacy; J Jones; S R Whittemore; D L Haviland; R A Wetsel; S R Barnum
Journal:  J Neuroimmunol       Date:  1995-08       Impact factor: 3.478

View more
  68 in total

Review 1.  Roles of the complement system in human neurodegenerative disorders: pro-inflammatory and tissue remodeling activities.

Authors:  Philippe Gasque; Jim W Neal; Sim K Singhrao; Eamon P McGreal; Yann D Dean; Beek Johan Van; B Paul Morgan
Journal:  Mol Neurobiol       Date:  2002-02       Impact factor: 5.590

2.  The C5a receptor is expressed in normal renal proximal tubular but not in normal pulmonary or hepatic epithelial cells.

Authors:  A Fayyazi; O Scheel; T Werfel; S Schweyer; M Oppermann; O Götze; H J Radzun; J Zwirner
Journal:  Immunology       Date:  2000-01       Impact factor: 7.397

Review 3.  Inhibition of complement as a therapeutic approach in inflammatory central nervous system (CNS) disease.

Authors:  S R Barnum
Journal:  Mol Med       Date:  1999-09       Impact factor: 6.354

Review 4.  Chemotactic factors in cerebrospinal fluid during bacterial meningitis.

Authors:  Petra J G Zwijnenburg; Tom van der Poll; John J Roord; A Marceline van Furth
Journal:  Infect Immun       Date:  2006-03       Impact factor: 3.441

Review 5.  The role of the anaphylatoxins in health and disease.

Authors:  Andreas Klos; Andrea J Tenner; Kay-Ole Johswich; Rahasson R Ager; Edimara S Reis; Jörg Köhl
Journal:  Mol Immunol       Date:  2009-05-28       Impact factor: 4.407

Review 6.  Neuroprotection in stroke by complement inhibition and immunoglobulin therapy.

Authors:  T V Arumugam; T M Woodruff; J D Lathia; P K Selvaraj; M P Mattson; S M Taylor
Journal:  Neuroscience       Date:  2008-07-12       Impact factor: 3.590

7.  Ischemia-reperfusion Injury in the Brain: Mechanisms and Potential Therapeutic Strategies.

Authors:  Lin L; Wang X; Yu Z
Journal:  Biochem Pharmacol (Los Angel)       Date:  2016-06-20

8.  Inhibition of C5a receptor alleviates experimental CNS lupus.

Authors:  Alexander Jacob; Bradley Hack; Tao Bai; James R Brorson; Richard J Quigg; Jessy J Alexander
Journal:  J Neuroimmunol       Date:  2010-03-05       Impact factor: 3.478

9.  Expression of C5a and its receptor following spinal cord ischemia reperfusion injury in the rat.

Authors:  Q Dong; L Sun; L Peng; B Yan; J Lv; G Wang; S Gong
Journal:  Spinal Cord       Date:  2015-04-28       Impact factor: 2.772

10.  Genetic and pharmacologic inhibition of complement impairs endothelial cell function and ablates ovarian cancer neovascularization.

Authors:  Selene Nunez-Cruz; Phyllis A Gimotty; Matthew W Guerra; Denise C Connolly; You-Qiang Wu; Robert A DeAngelis; John D Lambris; George Coukos; Nathalie Scholler
Journal:  Neoplasia       Date:  2012-11       Impact factor: 5.715

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.